Finch Therapeutics Group, Inc.

The current price of FNCH is 2.36 USD — it has decreased by 6.35% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Finch Therapeutics Group, Inc. stocks are traded under the ticker FNCH.

Finch Therapeutics Group, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

FNCH stock is 21.27% volatile and has beta coefficient of 0.88. Check out the list of the most volatile stocks — is Finch Therapeutics Group, Inc. there?

FNCH earnings for the last quarter are −16.80 USD whereas the estimation was −9.90 USD which accounts for −69.70% surprise. Estimated earnings for the next quarter are −2.70 USD. See more details about Finch Therapeutics Group, Inc. earnings.

Finch Therapeutics Group, Inc. revenue for the last quarter amounts to ‪138.00 K‬ USD despite the estimated figure of ‪750.00 K‬ USD. In the next quarter revenue is expected to reach ‪400.00 K‬ USD.

Yes, you can track Finch Therapeutics Group, Inc. financials in yearly and quarterly reports right on TradingView.

FNCH net income for the last quarter is ‪−3.04 M‬ USD, while the quarter before that showed ‪−2.42 M‬ USD of net income which accounts for −25.87% change. Track more Finch Therapeutics Group, Inc. financial stats to get the full picture.

Today Finch Therapeutics Group, Inc. has the market capitalization of ‪4.05 M‬, it has decreased by 10.57% over the last week.

No, FNCH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, FNCH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Finch Therapeutics Group, Inc. stock right from TradingView charts — choose your broker and connect to your account.

FNCH reached its all-time high on Mar 19, 2021 with the price of 675.68 USD, and its all-time low was 1.86 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 1.00 employees. See our rating of the largest employees — is Finch Therapeutics Group, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Finch Therapeutics Group, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Finch Therapeutics Group, Inc. stock shows the sell signal. See more of Finch Therapeutics Group, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Finch Therapeutics Group, Inc. EBITDA is ‪−34.07 M‬ USD, and current EBITDA margin is ‪−30.36 K‬%. See more stats in Finch Therapeutics Group, Inc. financial statements.